Literature DB >> 11668682

Generation dependent reduction of tTA expression in double transgenic NZL-2/tTA(CMV) mice.

L M Fedorov, O Y Tyrsin, O Sakk, A Ganscher, U R Rapp.   

Abstract

Despite the overall successful application of the tet-system to regulate gene expression in vitro and in vivo, nothing is known so far about the long-term stability of this system in transgenic mice. In this study, mice of generation F2, F3, F4, or F10 of two independent tTA(CMV) transgenic lines were bred with NZL-2 mice containing a tTA-responsive bidirectional promoter that allows the simultaneous expression of two reporter genes encoding luciferase and beta-galactosidase. Analysis of the expression of transgenes in double transgenic mice revealed a dramatic reduction of tTA transactivator mRNA over time. As a consequence, the expression of both reporter genes was gradually reduced from generation to generation in tissues of embryonic and adult NZL-2/tTA(CMV) mice. Luciferase activity in NZL-2/tTA(CMV)(F10) mice was reduced 8-10-fold compared to NZL-2/ tTA(CMV)(F2) mice, and beta-galactosidase expression was no longer detectable. In summary, we describe the long-term instability of the tet-system in our NZL-2/tTA(CMV) double transgenic mice. The molecular basis of this observation and experimental tools to overcome this limitation need to be addressed in future. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668682     DOI: 10.1002/gene.10007

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  3 in total

1.  Unexpected expression pattern of tetracycline-regulated transgenes in mice.

Authors:  M Bao-Cutrona; P Moral
Journal:  Genetics       Date:  2009-02-09       Impact factor: 4.562

2.  A previously functional tetracycline-regulated transactivator fails to target gene expression to the bone.

Authors:  Eva Schmidt; Maria Eriksson
Journal:  BMC Res Notes       Date:  2011-08-11

3.  Low levels of the reverse transactivator fail to induce target transgene expression in vascular smooth muscle cells.

Authors:  Nikenza Viceconte; Tomás McKenna; Maria Eriksson
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.